Paragraph 559 I1
United Kingdom
Commission Implementing Decision No 2011/252/EU allowing Member States to extend provisional authorisations granted for the new active substances ascorbic acid, ipconazole, spiromesifen, topramezone, and Pseudomonas sp. strain DSMZ 13134.
Annotations
Commencement
- I1
Sch. 2 para. 559 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)